Live Breaking News & Updates on Glenmark pharmaceuticals inc

Stay informed with the latest breaking news from Glenmark pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Glenmark pharmaceuticals inc and stay connected to the pulse of your community

Lupin, Glenmark recall drugs in US market: USFDA

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Lupin is recalling 26,352 bottles of Rifampin Capsules (300 mg), an antibiotic medication in the US market.

India , United-states , Aurangabad , Maharashtra , Australia , Japan , American , Natco-pharma , Kothur-telangana , Lupin-pharmaceuticals-inc , Drug-administration , Glenmark-pharmaceuticals-inc

Lupin, Glenmark and Natco Pharma recall drugs in US market due to manufacturing issues

Lupin, Glenmark and Natco Pharma recall drugs in US market due to manufacturing issues
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , Japan , Australia , United-states , Aurangabad , Maharashtra , American , Natco-pharma , Kothur-telangana , Glenmark-pharmaceuticals-inc , Drug-administration , Lupin-pharmaceuticals-inc

Glenmark, Lupin recalling drugs in American market: USFDA

US News: Lupin, Glenmark, Natco Pharma recall various drugs in the US due to manufacturing issues. USFDA initiates recalls for health risks. India maintains a

United-states , Aurangabad , Maharashtra , India , American , Natco-pharma , Glenmark-pharmaceuticals-inc , Us-food-drug-administration , Lupin-pharmaceuticals , Drug-administration , Rifampin-capsules , Baltimore-based-lupin

DOJ Criminal Antitrust Enforcement in 2023 Reviewed

DOJ Criminal Antitrust Enforcement in 2023 Reviewed
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.

Tokyo , Japan , Canada , Criminal-division , North-carolina , United-states , South-korea , Georgia , Mexico , Michigan , New-york , Connecticut

United States Active Pharmaceutical Ingredient Market

United States Active Pharmaceutical Ingredient Market
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Dublin , Ireland , United-states , Eli-lilly , Novartis-inc , Lupin-pharmaceuticals-inc , Abbvie-inc , Glaxosmithkline-plc , Advancements-in-oncology-drug-research , Pfizer-inc , Teva-pharmaceuticals-united-states , Merck-co-inc

Nifty, Sensex Struggling to head higher - Weekly Closing Report

In a persistent trend, markets maintained a consolidated range, closing flat in yet another session today. Despite this, both benchmarks made a fourth consecutive weekly gain, primarily fueled by anticipations of a peaking interest rate scenario in the U.S. and Europe. In global market highlights, the Eurozone composite PMI showed a marginal uptick to 47.1 in November 2023 from a near three-year low of 46.5 in October 2023.

Okhla , Delhi , India , Visakhapatnam , Andhra-pradesh , Tejgaon , Bangladesh-general- , Bangladesh , Pune , Maharashtra , Israel , Belgium

Nifty, Sensex Still Trendless - Thursday Closing Report

On Thursday, 2064 stocks advanced, 1636 declined and 144 remained unchanged, with an advance decline ratio of 1.26 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader markets.

Dhaka , Bangladesh , Okhla , Delhi , India , United-states , Shyam , Rangpur , Bombay , Maharashtra , Tejgaon , Bangladesh-general-

Dr Reddy's, Glenmark, Zydus Recall Products In U.S. Due To Manufacturing Issues

In its latest enforcement report, the U.S. health regulator said Princeton-based Dr Reddy's Laboratories, Inc, a unit of the Hyderabad-based drug firm, is recalling 1,656 bottles of Montelukast sodium tablets.

Hyderabad , Andhra-pradesh , India , United-states , Glenmark-pharma , Drug-administration , Dr-reddy-laboratories-inc , Glenmark-pharmaceuticals-inc , Princeton-based-dr-reddy , Mahwah-based-glenmark-pharmaceuticals-inc , Mumbai-based-glenmark-pharma , Pharma